1. Home page
  2. Search

Data from: Stefanou DT, Bamias A, Episkopou H, Kyrtopoulos SA, Likka M, Kalampokas T, Photiou S, Gavalas N, Sfikakis PP, Dimopoulos MA, Souliotis VL (2014). Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer. PLos ONE

This item is provided by the institution :
National Hellenic Research Foundation (NHRF)   

Repository :
Helios - Repository of the National Hellenic Research Foundation (NHRF)  | repositories EKT   

see the original item page
in the repository's web site and access all digital files if the item*



Data from: Stefanou DT, Bamias A, Episkopou H, Kyrtopoulos SA, Likka M, Kalampokas T, Photiou S, Gavalas N, Sfikakis PP, Dimopoulos MA, Souliotis VL (2014). Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer. PLos ONE
Ερευνητικά δεδομένα
2014
QH506
Νεοπλάσματα. Όγκοι. Ογκολογία (περ. Καρκίνος, κακινογόνες ουσίες) (EL)
Neoplasms. Tumors. Oncology (Incl.cancer, carcinogens) (EN)
Clinical outcome (EN)
Platinum-based drugs (EN)
DNA damage response (EN)
γH2AX antigen staining (EN)
DNA adducts (EN)
Comet assay (EN)
Ovarian cancer (EN)
Apoptosis (EN)
English
© 2014 The authors/creators
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.el
National Hellenic Research Foundation (NHRF)
Helios - Repository of the National Hellenic Research Foundation (NHRF)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)